Methotrexate, hyperosmia, and migraine.
Zargari
Omid
O
D000328:Adult; D015897:Comorbidity; D003879:Dermatologic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects*; D008881:Migraine Disorders / Q000453:epidemiology*; D009325:Nausea / Q000139:chemically induced; D000857:Olfaction Disorders / Q000139:chemically induced*; D011565:Psoriasis / Q000188:drug therapy* / Q000453:epidemiology
D003879:Dermatologic Agents; D008727:Methotrexate